In this study, esketamine, a fast and effective antidepressant drug, was administered intraperitoneally to observe its effects on depression-like behavior, PSD-95 and CRMP2 protein expression, and dendritic spine plasticity in PFC neurons. The gene discussed is DPYSL2; the disease is depressive symptom measurement.